Hon ANDREW LITTLE: Well, decisions about the use of particular pharmaceuticals is typically reliant on data provided by the pharmaceutical company applying for the application to distribute and sell in the country. So I expect the director-general would be reliant on that as opposed to third-party sources of it. In your third question—would I prevail upon the director-general to make representations about how it should be administered—no, I do not have a clinical background. I do not regard myself as having clinical expertise. I'm reliant on advice from the director-general. I might ask the director-general from time to time what is an appropriate regime for New Zealand, but I am reliant on the director-general and the other experts that the director-general calls upon before any such decision would be made.